Taken together, compared with meso1 CAR T cells, meso3 CAR T cells express higher levels of CD107α upon activation and produce increased levels of IL-2, TNF-α, and IFN-γ cytokines against MSLN-positive tumor cells. The gene discussed is IFNG; the disease is neoplasm.